Patents

AA Thornton’s letter of recommendation to the EPO 2019

AA Thornton’s advice to European Patent Office management EPO President Mr António Campinos invited AA Thornton to provide recommendations for the EPO’s next strategic plan, and we have done this. AA Thornton Partner Mike Jennings also participated in a review of EPO quality in Munich on 7 February, with the EPO Standing Advisory Committee’s quality… Read more »

Google Get Lucky

Google get lucky – Google win a patent dispute over their “I’m feeling lucky” button Google have been involved in a dispute with Israeli company Spring Ventures (previously Buy2 Networks) regarding their “I’m feeling lucky” button which, once clicked, takes the user straight to Google’s top-ranked search link. Spring Ventures asserted that the button infringed… Read more »

Julie Barrett-Major speaks at Queen Mary University

Reporting on the Queen Mary University’s Life Sciences, Cosmetics and Intellectual Property seminars for CNIPA   Consulting Patent Attorney Julie Barrett-Major recently gave two 3-hour seminars at the Queen Mary University of London (QMUL) earlier this month on Life Sciences, Cosmetics and Intellectual Property. The two seminars formed part of the QMUL’s programme of education and… Read more »

East Anglia Business Magazine: The Importance of Intellectual Property

The Importance of Intellectual Property   Associate Attorney, Christopher Burnett, recently wrote an article ‘The Importance of Intellectual Property’ for East Anglia in Business Magazine, and the full magazine can be read  here.. Chris’s article identifies different IP rights, what they protect and how they are obtained in order to then commercialise them. Below is… Read more »

An update on Supplementary Protection Certificates in Europe

European Commission proposes changes to Supplementary Protection Certificates Supplementary Protection Certificates (SPCs) are an intellectual property right that serve as an extension to a patent right (for up to five years) specific to pharmaceutical and plant products that must undergo extensive testing and clinical trials before being authorised by marketing authorities in Europe. Earlier in 2018,… Read more »

The year in review: AA Thornton on Battery Technology

 AA Thornton reflect on the past year in the battery and energy storage industries On the 4th and 5th of December, Patent Attorneys Marianne Privett and David Blair attended the ‘Battery and Energy Storage Show 2018’ hosted by Warwick University (with Matt Havron joining them on the 5th December). At the event, Marianne and David… Read more »

RACETECH: The problem of counterfeiting in Motorsport

Fake News! The problem of counterfeiting in Motorsport   Partner Alex Bone and Associate Patent Attorney, Stuart Greenwood recently wrote an article for the December / January issue of RACETECH magazine. Their article ‘Fake News!’ discussed how fake goods are increasingly a problem in the motorsport industry and offered advice on how to counter the… Read more »

Mike Jennings Chairs AI patenting panel at CIPA’s Computers and IP Conference

Patenting Artificial Intelligence – CIPA’s Computer Technology Committee Training   CIPA’s Computer Technology Committee provided an excellent update on ‘Computers and IP’ on 22 November in London, including contributions from AA Thornton partner Mike Jennings who chaired a panel discussing patentability of artificial intelligence. The panel focussed on the many technical applications of machine learning… Read more »

BioScience Today – Patenting aerospace medicines

Patenting aerospace medicines – the final frontier? Consulting Attorney, Julie Barrett-Major recently wrote for BioScience Today on the subject of Patenting aerospace medicines. You can find Julie’s article below, or read the full magazine here.      Should you wish to discuss this topic, please contact the author, Julie Barrett-Major, or your usual AA… Read more »

Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (Pregabalin/Lyrica)

Sufficiency and Infringement of Second Medical Use Patents Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (Pregabalin/Lyrica)   The Supreme Court of the United Kingdom has now released their long-awaited decision relating to the tests for sufficiency and infringement for second medical use patents, in particular those with so-called “Swiss-form”… Read more »

Categories

Archives